Other

Dataset Information

0

Network-based elucidation of colon cancer drug resistance by phosphoproteomic time-series analysis


ABSTRACT: Aberrant signaling pathway activity is a hallmark of tumorigenesis and progression, which has guided targeted inhibitor design for over 30 years. Yet, adaptive resistance mechanisms, induced by rapid, context-specific signaling network rewiring, continue to challenge therapeutic efficacy. By leveraging progress in proteomic technologies and network-based methodologies over the past decade we developed VESPA—an algorithm designed to elucidate mechanisms of cell response and adaptation to drug perturbations—and used it to analyze 7-point phosphoproteomic time series from colorectal cancer cells treated with clinically-relevant inhibitors and control media. Interrogation of tumor-specific enzyme/substrate interactions accurately inferred kinase and phosphatase activity, based on their inferred substrate phosphorylation state, effectively accounting for signal cross-talk and sparse phosphoproteome coverage. The analysis elucidated time-dependent signaling pathway response to each drug perturbation and, more importantly, cell adaptive response and rewiring that was experimentally confirmed by CRISPRko assays, suggesting broad applicability to cancer and other diseases. 

ORGANISM(S): Homo sapiens

PROVIDER: GSE224396 | GEO | 2023/03/09

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-02-04 | MSV000091204 | MassIVE
2023-02-18 | PXD036826 | Pride
| PRJNA434496 | ENA
2024-08-10 | PXD050545 | Pride
2021-05-11 | PXD021877 | Pride
| PRJNA655674 | ENA
2020-11-20 | PXD020183 | Pride
2016-03-21 | GSE77868 | GEO
2020-02-28 | PXD014865 | Pride
2023-08-27 | PXD035050 | Pride